Terms: = Kidney tumors AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM
134 results:
1. Biphasic papillary (biphasic squamoid alveolar) renal cell carcinoma: a clinicopathologic and molecular study of 17 renal cell carcinomas including 10 papillary adenomas.
Nova-Camacho LM; Acosta AM; Akgul M; Panizo A; Galea LA; Val-Carreres A; Talavera JA; Guerrero-Setas D; Martin-Arruti M; Ruiz I; García-Martos M; Sangoi AR
Virchows Arch; 2024 Mar; 484(3):441-449. PubMed ID: 38388964
[TBL] [Abstract] [Full Text] [Related]
2. Clinical experience of bench surgery combined with autotransplantation after three-dimensional laparoscopic nephrectomy for the treatment of highly complex renal tumor.
Xu Y; Huang J; Fan X; Wang Z; Lou J; Liu X; Weng G
World J Surg Oncol; 2023 Nov; 21(1):373. PubMed ID: 38031058
[TBL] [Abstract] [Full Text] [Related]
3. Associations between BMI in youth and site-specific cancer in men-A cohort study with register linkage.
Onerup A; Mehlig K; Af Geijerstam A; Ekblom-Bak E; Kuhn HG; Lissner L; Rosengren A; Börjesson M; Åberg M
Obesity (Silver Spring); 2024 Feb; 32(2):376-389. PubMed ID: 37927128
[TBL] [Abstract] [Full Text] [Related]
4. A large-scale microRNA transcriptome-wide association study identifies two susceptibility microRNAs, miR-1307-5p and miR-192-3p, for colorectal cancer risk.
Chen Z; Lin W; Cai Q; Kweon SS; Shu XO; Tanikawa C; Jia WH; Wang Y; Su X; Yuan Y; Wen W; Kim J; Shin A; Jee SH; Matsuo K; Kim DH; Wang N; Ping J; Shin MH; Ren Z; Oh JH; Oze I; Ahn YO; Jung KJ; Gao YT; Pan ZZ; Kamatani Y; Han W; Long J; Matsuda K; Zheng W; Guo X
Hum Mol Genet; 2024 Feb; 33(4):333-341. PubMed ID: 37903058
[TBL] [Abstract] [Full Text] [Related]
5. [Treatment outcome of laparoscopic partial nephrectomy in patients with renal tumors of moderate to high complexity].
Qiu M; Zong YL; Wang BS; Yang B; Xu CX; Sun ZH; Lu M; Zhao L; Lu J; Liu C; Tian XJ; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):833-837. PubMed ID: 37807736
[TBL] [Abstract] [Full Text] [Related]
6. TERT Promoter Mutations Frequency Across Race, Sex, and Cancer Type.
El Zarif T; Machaalani M; Nawfal R; Nassar AH; Xie W; Choueiri TK; Pomerantz M
Oncologist; 2024 Jan; 29(1):8-14. PubMed ID: 37462445
[TBL] [Abstract] [Full Text] [Related]
7. A Contemporary Evaluation of Urological Outcomes After Renal Transplantation.
Kennedy A; Rice MK; Waguespack M; Xie WY; Al-Qaoud T; Malik RD
Urol Pract; 2023 Jan; 10(1):75-81. PubMed ID: 37103439
[TBL] [Abstract] [Full Text] [Related]
8. IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study.
Scovell JM; Stovsky M; Partin A; Lotan Y; Baniel J; Dineen M; Hafron J; Manickam K; Pliskin M; Wagner M; Kestranek A; Klein EA
Urology; 2023 May; 175():132-136. PubMed ID: 36804443
[TBL] [Abstract] [Full Text] [Related]
9. Nanocurcumin preserves kidney function and haematology parameters in DMBA-induced ovarian cancer treated with cisplatin via its antioxidative and anti-inflammatory effect in rats.
Louisa M; Wanafri E; Arozal W; Sandhiutami NMD; Basalamah AM
Pharm Biol; 2023 Dec; 61(1):298-305. PubMed ID: 36708211
[TBL] [Abstract] [Full Text] [Related]
10. Association of metabolic syndrome and its components with the risk of kidney cancer: A cohort-based case-control study.
Jiang R; Li Z; Wang X; Cai H; Wu S; Chen S; Hu H
Technol Health Care; 2023; 31(4):1235-1244. PubMed ID: 36617800
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic evaluation based on radiological morphological characteristic for tumors larger than 7 cm in renal cell carcinoma.
Huang J; Dai C; Zhang S; Li Y; He M; Xu P; Zhou J; Guo J; Wang H
J Cancer Res Clin Oncol; 2023 Jan; 149(1):263-270. PubMed ID: 36520216
[TBL] [Abstract] [Full Text] [Related]
12. The geriatric nutritional risk index predicts complications after nephrectomy for renal cancer.
Riveros C; Chalfant V; Bazargani S; Bandyk M; Balaji KC
Int Braz J Urol; 2023; 49(1):97-109. PubMed ID: 36512458
[TBL] [Abstract] [Full Text] [Related]
13. Cancer-specific Mortality After Cryoablation vs Heat-based Thermal Ablation in T1a Renal Cell Carcinoma.
Sorce G; Hoeh B; Hohenhorst L; Panunzio A; Tappero S; Tian Z; Kokorovic A; Larcher A; Capitanio U; Tilki D; Terrone C; Chun FKH; Antonelli A; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
J Urol; 2023 Jan; 209(1):81-88. PubMed ID: 36440817
[TBL] [Abstract] [Full Text] [Related]
14. Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes.
Na Y; Kim SW; Park IB; Choi SJ; Nam S; Jung J; Lee DH
J Clin Endocrinol Metab; 2022 Nov; 107(11):3022-3034. PubMed ID: 36108097
[TBL] [Abstract] [Full Text] [Related]
15. Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma.
Bedke J; Rini BI; Plimack ER; Stus V; Gafanov R; Waddell T; Nosov D; Pouliot F; Soulières D; Melichar B; Vynnychenko I; Azevedo SJ; Borchiellini D; McDermott RS; Tamada S; Nguyen AM; Wan S; Perini RF; Rhoda Molife L; Atkins MB; Powles T
Eur Urol; 2022 Oct; 82(4):427-439. PubMed ID: 35843776
[TBL] [Abstract] [Full Text] [Related]
16. Circ_0008717 promotes renal cell carcinoma progression by upregulating FBXO17 via targeting miR-217.
Shen S; Jiang M; Deng W; Liu X; Xiong J; Zeng Z; Zhao H; Zeng X; Fu B
J Gene Med; 2022 Nov; 24(11):e3418. PubMed ID: 35357059
[TBL] [Abstract] [Full Text] [Related]
17. Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma.
Dong Y; Ma WM; Yang W; Hao L; Zhang SQ; Fang K; Hu CH; Zhang QJ; Shi ZD; Zhang WD; Fan T; Xia T; Han CH
BMC Cancer; 2021 Oct; 21(1):1135. PubMed ID: 34688260
[TBL] [Abstract] [Full Text] [Related]
18. Trends and safety of robot-assisted partial nephrectomy during the initial 2-year period after government approval in Japan: A nationwide database study from 2016 to 2018.
Yokoyama M; Ishioka J; Toba M; Fukushima H; Tanaka H; Yoshida S; Matsuoka Y; Ai M; Fushimi K; Fujii Y
Int J Urol; 2021 Dec; 28(12):1268-1272. PubMed ID: 34528301
[TBL] [Abstract] [Full Text] [Related]
19. Differentiating Benign from Malignant Renal tumors Using T2- and Diffusion-Weighted Images: A Comparison of Deep Learning and Radiomics Models Versus Assessment from Radiologists.
Xu Q; Zhu Q; Liu H; Chang L; Duan S; Dou W; Li S; Ye J
J Magn Reson Imaging; 2022 Apr; 55(4):1251-1259. PubMed ID: 34462986
[TBL] [Abstract] [Full Text] [Related]
20. Outcomes in robot-assisted partial nephrectomy for imperative vs elective indications.
Tan JS; Sathianathen N; Cumberbatch M; Dasgupta P; Mottrie A; Abaza R; Ho Rha K; Yuvaraja TB; Parekh DJ; Capitanio U; Ahlawat R; Rawal S; Buffi NM; Sivaraman A; Maes KK; Gautam G; Porpiglia F; Turkeri L; Bhandari M; Challacombe B; Roscoe Porter J; Rogers CR; Moon DA
BJU Int; 2021 Dec; 128 Suppl 3():30-35. PubMed ID: 34448346
[TBL] [Abstract] [Full Text] [Related]
[Next]
